Esra Oğuz, Tuğçe Tayyar, Aysun Özdemir, Onur İnam, Serdar Tort
{"title":"Fabrication and characterization of Coenzyme Q10-loaded nanofibers for potential biomedical applications.","authors":"Esra Oğuz, Tuğçe Tayyar, Aysun Özdemir, Onur İnam, Serdar Tort","doi":"10.1080/10837450.2025.2570281","DOIUrl":null,"url":null,"abstract":"<p><p>Coenzyme Q10 (CoQ10) is an essential molecule that plays a role in mitochondrial oxidative phosphorylation and acts as a powerful antioxidant. In this study, CoQ10-loaded nanofibers were developed and characterized <i>via</i> electrospinning method. SEM analyses showed that the fiber diameters ranged between 487 and 2163 nm, and that CoQ10 loading did not disrupt the fiber structure but reduced the diameter. It was determined that bead formation was observed only in the F1 formulation due to the low viscosity (73.09 mPas) and conductivity (1.66 mS/cm) values. The F4 formulation, containing Eudragit RL100 and Kollidon 90F, was selected as the final formulation because it exhibited the highest tensile strength (1.49 MPa) and the smallest fiber diameter (1306 nm). <i>In vitro</i> drug release studies demonstrated that the F4 formulation released only 4% of CoQ10 within 24 h, indicating a controlled release profile. The biocompatibility of this formulation was evaluated through a cytotoxicity assay using the SH-SY5Y neuroblastoma cell line. After seven days of treatment, the CoQ10-loaded nanofiber group showed a cell viability of 101.65%. This result indicates that the nanofibers did not exhibit any cytotoxic effect; on the contrary, they demonstrated potential to support cell proliferation. These findings suggest that CoQ10-loaded nanofibers hold promise for biomedical applications.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-16"},"PeriodicalIF":2.5000,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Development and Technology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10837450.2025.2570281","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Coenzyme Q10 (CoQ10) is an essential molecule that plays a role in mitochondrial oxidative phosphorylation and acts as a powerful antioxidant. In this study, CoQ10-loaded nanofibers were developed and characterized via electrospinning method. SEM analyses showed that the fiber diameters ranged between 487 and 2163 nm, and that CoQ10 loading did not disrupt the fiber structure but reduced the diameter. It was determined that bead formation was observed only in the F1 formulation due to the low viscosity (73.09 mPas) and conductivity (1.66 mS/cm) values. The F4 formulation, containing Eudragit RL100 and Kollidon 90F, was selected as the final formulation because it exhibited the highest tensile strength (1.49 MPa) and the smallest fiber diameter (1306 nm). In vitro drug release studies demonstrated that the F4 formulation released only 4% of CoQ10 within 24 h, indicating a controlled release profile. The biocompatibility of this formulation was evaluated through a cytotoxicity assay using the SH-SY5Y neuroblastoma cell line. After seven days of treatment, the CoQ10-loaded nanofiber group showed a cell viability of 101.65%. This result indicates that the nanofibers did not exhibit any cytotoxic effect; on the contrary, they demonstrated potential to support cell proliferation. These findings suggest that CoQ10-loaded nanofibers hold promise for biomedical applications.
期刊介绍:
Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology.
Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as:
-Preformulation and pharmaceutical formulation studies
-Pharmaceutical materials selection and characterization
-Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation
-QbD in the form a risk assessment and DoE driven approaches
-Design of dosage forms and drug delivery systems
-Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies
-Drug delivery systems research and quality improvement
-Pharmaceutical regulatory affairs
This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.